2 beginner stocks to kick-start a portfolio

Edward Sheldon looks at two stocks that he believes could be ideal choices for those looking to start an investment portfolio.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Buying shares for the first time can be a daunting experience. However in my opinion, the key is to focus on putting together a portfolio of high quality companies that pay regular dividends with the intention of holding these companies for the long term and allowing compounding to work its magic. With that in mind, here’s two stocks I believe could be excellent choices for beginners.

GlaxoSmithKline

GlaxoSmithKline (LSE: GSK) has excellent potential as a starter stock to my mind, as the world’s ageing population should provide significant tailwinds to the healthcare industry over the medium-to-long term and the healthcare giant looks well placed to benefit.

The company is currently undergoing a transition period, with management deciding to focus less on blockbuster drugs and more on vaccines and consumer health products. After an asset swap with Novartis in 2015, 45% of revenue now comes from selling products such as Beechams Cold & Flu and Sensodyne toothpaste, and the new business model should result in more stable and consistent revenues and cash flows.

GlaxoSmithKline’s dividend yield of 5.1% is one of the higher yields in the FTSE 100 and while there has been some concern in recent years as to whether this is sustainable, with earnings forecast to rise 40% and 10% for FY2016 and FY2017, the chances of a dividend cut are looking less likely to me.

After trading as high as 1727p in October last year, the shares have fallen 10% in the last few months to now trade at 1,560p and at this price, with a P/E ratio of a reasonable 15.4, they look good value. For those new to investing, I believe GlaxoSmithKline has strong potential as a core holding.

The City of London Investment Trust

The City of London Investment Trust (LSE: CTY) seems like another ideal beginner’s stock for the main reason that, although the trust trades like a regular share, it’s actually a portfolio of around 120 companies, thus offering fantastic diversification benefits and a low risk profile.

The trust’s objective is to provide long-term capital and income growth and it places a strong focus on rewarding shareholders with regular dividend payouts. The current yield is approximately 4% and incredibly, the dividend has been increased every year since 1966. 

Fund manager Job Curtis takes a cautious approach to investing, mainly going for equities on the London Stock Exchange, and the top five holdings include blue-chip names such as Royal Dutch Shell, British American Tobacco, HSBC, BP and Diageo. The trust is however allowed to invest in smaller FTSE 350 companies and therefore has access to companies with higher growth potential.

Bear in mind that as a portfolio of 120 stocks, it’s likely to rise and fall with market fluctuations and with market turbulence never too far away, there’s no guarantee that an investment in the City of London Investment Trust will be smooth sailing. However it has weathered many economic events and plenty of market turmoil through its conservative investment strategy, returning an annualised 12% per year over the last five years. As such I believe it’s an excellent choice for new investors looking to dip their toes into the market waters.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon owns shares in GlaxoSmithKline, City of London Investment Trust, Royal Dutch Shell B and Diageo. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended BP, Diageo, HSBC Holdings, and Royal Dutch Shell B. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

2 FTSE 100 stocks hedge funds have been buying

A number of investors have been seeing opportunities in FTSE 100 shares recently. And Stephen Wright thinks two in particular…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Would it be pure madness to pile into the S&P 500?

The S&P 500 is currently in the midst of a skyrocketing bull market, but valuations are stretched. Is there danger…

Read more »

Investing Articles

If I’d put £20k into the FTSE 250 1 year ago, here’s what I’d have today!

The FTSE 250 has outperformed the bigger FTSE 100 over the last year. Roland Head highlights a mid-cap share to…

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Growth Shares

The Scottish Mortgage share price is smashing the FTSE 100 again

Year to date, the Scottish Mortgage share price has risen far more than the Footsie has. Edward Sheldon expects this…

Read more »

Investing Articles

As H1 results lift the Land Securities share price, should I buy?

An improving full-year outlook could give the Land Securities share price a boost. But economic pressures on REITs are still…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

How much are Rolls-Royce shares really worth as we approach 2025?

After starting the year at 300p, Rolls-Royce shares have climbed to 540p. But are they really worth that much? Edward…

Read more »

Investing Articles

Despite rocketing 33% this hidden FTSE 100 gem is still dirt cheap with a P/E under 5!

Harvey Jones has been tracking this under -the-radar FTSE 100 growth stock for some time. He thinks it looks a…

Read more »

Dividend Shares

How I could earn a juicy second income starting with just £250

Jon Smith explains how investing a regular amount each month in dividend stocks with above average yields can build a…

Read more »